Jonathan Wang, PhD, MBAPartner, Founding Partner at OrbiMed, OrbiMed Asia
Dr. Jonathan Wang is a Partner at OrbiMed, the world’s largest healthcare-dedicated investment firm, where he founded OrbiMed Asia. He is a HKEX Biotech Advisory Panel member and is a co-founder and former Chairman of BayHelix, a premier organization of Chinese healthcare business leaders. Under the supervision of Eric Kandel, a Nobel Laureate, he obtained a Ph.D. in Neurobiology from Columbia University. He was rewarded the Howard Hughes Medical Institute (HHMI) Research Fellowship at Columbia. He also earned an MBA from Stanford University. He has close to 30 years of healthcare and life sciences experience, spanning investment, entrepreneurship, finance and research. He has been named one of the top 10 healthcare investors in China (ChinaVenture) and has invested in many successful companies, such as ZAI Lab, Genewiz, Apollomics, ForteBIO and EA. He serves as the Chairman of Apollomics Pharmaceuticals.